Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Background: Bone metastases are a common painful and debilitating consequence of castration-resistant prostate cancer (CPRC). Bone pain may predict patients' prognosis and there is a need to ...

In mouse models of prostate cancer, MTX-101 delivered twice a week reduced tumor growth, lung metastases, bone remodeling, and tissue loss induced by the presence of metastatic cancer cells in the ...

Prevalence of bone loss and fractures in men receiving ADT Table 2 Fracture risk in men with nonmetastatic prostate cancer receiving GnRH agonist therapy compared with those not receiving GnRH ...

The difficulty of monitoring treatment response adds to the challenge of treating bone metastases Advanced prostate cancer often spreads to the bones, causing bone metastases. Unlike with tumours or ...

When cancer spreads from where it started to another part of the body, it is called metastasis. These metastatic cancer cells are the same type of cancer as the primary tumor. For example, if prostate ...

The test can spot signs that the disease has metastasized, meaning it has spread beyond the prostate to other parts of the body. When this process begins, the cancer is often small and difficult ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

This summer I was diagnosed with stage four, metastatic prostate cancer. Boy is that a punch in the stomach to hear!